OTLCOTCHealthcare · Biotechnology

Oncotelic Therapeutics, Inc.

$0.05-0.43%($-0.00)

TickerSpark Score

54/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OTLC research report →

52-Week Range38% of range

Low $0.02

Current $0.05

High $0.11

Companywww.oncotelic.com

Oncotelic Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus.

CEO: Vuong Trieu
IPO: 1993
Employees: 26
HQ: Agoura Hills, CA, US

Price Chart

-9.56% · this period

Valuation

Market Cap: $24.10M
P/E: 0.10
P/S: 0.00
P/B: 0.00
EV/EBITDA: -3490812.62
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: 0.00%
ROIC: -0.00%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $249.28M · 105.51%
EPS: $0.59 · 5367.86%
Op Income: $-3,186,599
FCF YoY: -186843971.13%

Performance & Tape

52W High: $0.11
52W Low: $0.02
50D MA: $0.04
200D MA: $0.07
Beta: -0.54
Avg Volume: 298.68K

Get TickerSpark's AI analysis on OTLC

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Jan 22, 26	Trieu Vuong	director, 10 percent owner, officer: CHAIRMAN AND CEO	other	4,426	$0
Nov 17, 25	Trieu Vuong	director, 10 percent owner, officer: CHAIRMAN AND CEO	other	4,065	$0
Jul 8, 25	Trieu Vuong	director, 10 percent owner, officer: CHAIRMAN AND CEO	buy	94,736	$473.68
Jul 9, 25	Trieu Vuong	director, 10 percent owner, officer: CHAIRMAN AND CEO	buy	1	$0.005
Jul 10, 25	Trieu Vuong	director, 10 percent owner, officer: CHAIRMAN AND CEO	buy	104,000	$520
Jan 31, 25	Trieu Vuong	director, 10 percent owner, officer: CHAIRMAN AND CEO	buy	63,775	$1.79K
Jan 30, 25	Trieu Vuong	director, 10 percent owner, officer: CHAIRMAN AND CEO	buy	100,003	$2.80K
Jan 29, 25	Trieu Vuong	director, 10 percent owner, officer: CHAIRMAN AND CEO	buy	183,066	$5.13K
Nov 22, 24	Trieu Vuong	director, 10 percent owner, officer: CHAIRMAN AND CEO	buy	298,499	$8.63K
Aug 23, 24	Trieu Vuong	director, 10 percent owner, officer: CHAIRMAN AND CEO	buy	500,000	$10.00K